AtriCure to Announce Third Quarter 2026 Financial Results
Key Highlights
- ➤AtriCure will release third quarter 2026 financial results November 3, 2026
- ➤AtriCure will host an audio webcast at 4:30 p.m. Eastern Time
- ➤AtriCure’s Isolator Synergy Ablation System has FDA approval for persistent Afib
- ➤AtriCure’s AtriClip products are the most widely sold LAA management devices worldwide
AtriCure, Inc. (Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2026 financial results on Tuesday, November 3, 2026.
AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, November 3, 2026, to discuss its third quarter financial results. Those interested in listening to the conference call should register online using this link . Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the audio webcast will be available at https://ir.atricure.com/events-and-presentations/events .
Get started
Create a free account to read the full story.